Formosa Chemicals & Fibre (1326) Q3 2025 earnings summary

Executive summary

• Report covers consolidated financials for the nine months ended September 30, 2025 and 2024, with a qualified review opinion due to some subsidiaries and equity-method investments not audited independently, representing up to 19% of assets and significant portions of comprehensive income.

• The group operates across petrochemicals, plastics, textiles, green energy, and biomedical segments, with extensive related party transactions and global operations.

Financial highlights

• Operating revenue for the nine months ended September 30, 2025 was NT$222.0 billion, down 17% year-over-year from NT$267.3 billion.

• Net loss attributable to owners for the nine months ended September 30, 2025 was NT$5.5 billion, compared to net income of NT$1.4 billion in the prior year.

• Basic loss per share for the nine months ended September 30, 2025 was NT$0.94, versus earnings per share of NT$0.25 for the same period last year.

• Gross margin declined to 3% from 4% year-over-year, reflecting lower sales and higher costs.

• Cash and cash equivalents at September 30, 2025 were NT$17.8 billion, down from NT$24.4 billion at December 31, 2024.

Outlook and guidance

• Management notes adoption of new IFRS standards but does not expect significant impact on financial condition or performance.

• No explicit forward-looking guidance provided.